STOCK TITAN

Heska Fourth Quarter and Full Year 2021 Financial Results and Earnings Call Scheduled for February 28, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Heska Corporation (NASDAQ: HSKA) will announce its fourth quarter and full year 2021 financial results on February 28, 2022, before market open. An earnings call is scheduled at 9 a.m. MT / 11 a.m. ET to discuss the results. The call can be accessed via phone and will also be webcast live on the company’s investor relations site. A replay will be available from 2 p.m. ET on February 28 through March 14, 2022. Heska manufactures advanced veterinary diagnostic products across North America and internationally.

Positive
  • Scheduled earnings call on February 28, 2022, provides transparency.
  • Potential for positive financial results anticipated by market.
Negative
  • None.

LOVELAND, Colo., Jan. 31, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products and solutions, will report its fourth quarter and full year 2021 financial performance in a press release before the market opens on Monday, February 28, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.

To access the conference call:
From within the United States, please dial 1-800-239-9838
From outside of the United States, please dial 1-323-794-2551
Reference Conference ID: 3732352

The earnings call will be webcast live from the Company's investor relations website at  Heska Fourth Quarter and Full Year 2021 Earnings Call Webcast.

A telephonic replay will be available at 2 p.m. ET on February 28 through 11:59 p.m. ET on March 14, 2022 and the webcast will be archived on the Company's website for 90 days.

To access the replay:
From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 3732352

About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health. For more information, please visit www.heska.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-fourth-quarter-and-full-year-2021-financial-results-and-earnings-call-scheduled-for-february-28-2022-301471094.html

SOURCE Heska Corporation

FAQ

When will Heska report its fourth quarter and full year 2021 results?

Heska will report its results on February 28, 2022.

What time is the earnings call for Heska?

The earnings call is scheduled for 9 a.m. MT / 11 a.m. ET on February 28, 2022.

How can I access the Heska earnings call?

You can access the call by dialing 1-800-239-9838 from the U.S. or 1-323-794-2551 internationally.

Will there be a replay of the Heska earnings call?

Yes, a telephonic replay will be available from 2 p.m. ET on February 28 through 11:59 p.m. ET on March 14, 2022.

What services does Heska provide?

Heska offers advanced veterinary diagnostic and specialty healthcare products, including lab testing instruments and digital imaging.

HSKA

NASDAQ:HSKA

HSKA Rankings

HSKA Latest News

HSKA Stock Data

1.31B
10.24M
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Loveland